Epstein-Barr virus-related disorders in children undergoing renal transplantation with tacrolimus-based immunosuppression

Transplantation

Volumn 68, Issue 7, 1999, Pages 997-1003

  Ellis, Demetrius ^a   Jaffe, Ronald ^a   Green, Michael ^a   Janosky, Janine J ^a   Lombardozzi Lane, Susan ^a   Shapiro, Ron ^a   Scantlebury, Velma ^a   Vivas, Carlos ^a   Jordan, Mark L ^a  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TACROLIMUS;

ARTICLE; CHILD; EPSTEIN BARR VIRUS; FOLLOW UP; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTIOUS MONONUCLEOSIS; KIDNEY TRANSPLANTATION; LYMPHOMA; LYMPHOPROLIFERATIVE DISEASE; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; VIRUS INFECTION;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; FOLLOW-UP STUDIES; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; LYMPHOPROLIFERATIVE DISORDERS; MALE; PROSPECTIVE STUDIES; TACROLIMUS;

EID: 0033569964     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199910150-00017     Document Type: Article

References (17)

1. Ellis D. Clinical use of tacrolimus (FK-506) in infants and children with renal transplants. Pediatr Nephrol 1995; 9: 487.
2. Shapiro R, Scantlebury VP, Jordan ML, Vivas C, Tzakis AG, Ellis D, et al. FK506 in pediatric kidney transplantation -primary and rescue experience. Pediatr Nephrol 1995; 9: S43.
3. Ellis D. Current expectations in pediatric renal transplantation. Current Opin Organ Transplant 1996; 1: 37.
4. The North American Pediatric Renal Transplant Cooperative Study (NAPRTCS): NAPRTCS 1997 data. A. Tejani, Director, NAPRTCS Clinical Coordinating Center, July 1998.
5. Hebert D, Sullivan EK. Malignancy and posttransplant lymphoproliferative disorder (PTLD) in pediatric renal transplant recipients: a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). Pediatr Transplant 1998; 2 (suppl 1): 57.
6. Rowe DT, Reyes LQUJ, Jabbour N, et al. Use of quantitative competitive PCR to measure Epstein-Barr Virus genome load in the peripheral blood of pediatric transplant patients with lymphoproliferative disorders. J Microbiol 1997; 35: 1612.
7. Chang K, Chen Y, Shibata D, Weiss L. Description of an in situ hybridization methodology for detection of Epstein-Barr virus RNA in paraffin embedded tissues, with a survey or normal and neoplastic tissues. Diag Mol Pathol 1992; 1: 246.
8. Nalesnik MA, Jaffe R, Starzl TE, et al. The pathology of post-transplant lymphoproliferative disorders occurring in the setting of cyclosporine-A prednisone immunosuppression. Am J Pathol 1988; 133: 173.
9. Bock GH, Sullivan EK, Miller D, et al. Cytomegalovirus infections following renal transplantation - effects of antiviral prophylaxis: a report of the North American Pediatric Renal Transplant Cooperative Study. Pediatr Nephrol 1997; 11: 665.
10. Kuo PC, Dafoe DC, Alfrey EJ, Sibley RK, Scandling JD. Post-transplant lymphoproliferative disorders and Epstein-Barr virus prophylaxis. Transplantation 1995; 59(1): 135.
11. Cohen JI: Epstein-Barr virus and the immune system. JAMA 1997; 278(6): 510.
12. Liebowitz D: Epstein-Barr virus - an old dog with new tricks. N Engl J Med 1995; 332: 55.
13. Ho M, Jaffe R, Miller G, et al. The frequency of Epstein-Barr virus infection and associated lymphoproliferative syndrome after transplantation and its manifestations in children. Transplantation 1988; 45: 719.
14. Cox KL, Lawrence-Miyasaki LS, Garcia-Kennedy R, et al. An increased incidence of Epstein-Barr virus infection and lymphoproliferative disorder in young children on FK506 after liver transplantation. Transplantation 1995; 59: 524.
15. Neri A, Barriga F, Inghirami G, et al. Epstein-Barr virus infection precedes clonal expansion in Burkitt's and acquired immunodeficiency syndrome-associated lymphoma. Blood 1991; 77: 1092.
16. Knowles DM, Cesarman E, Chadburn A, et al.Correlative morphologic and molecular genetic analysis demonstrates three distinct categories of posttransplantation lymphoproliferative disorders. Blood 1995; 85(2): 552.
17. Green M, Reyes J, Rowe D. New strategies in the prevention and management of Epstein-Barr virus infection and posttransplant lymphoproliferative disease following solid organ transplantation. Current Opin Organ Transplant 1998; 3: 143.